Iran Press/America: The trial has not been announced publicly but the official reportedly said that participants will receive an experimental vaccine on Monday at the Kaiser Permanente Washington Health Research Institute in Seattle, the Associated Press reported, citing an unnamed US administration official.
According to the news outlet, US public health officials said that it would take a year to 18 months to fully validate any potential vaccine.
The experiment is said to be funded by the US National Institutes of Health (NIH), the primary governmental agency responsible for biomedical and public health research in the US.
The trial will reportedly include 45 young healthy volunteers who will be given different doses of the medicine.
The coronavirus pandemic in the US has prompted the Trump administration to take a package of preventive measures, including declaring a state of emergency across the country, closing borders and banning travel to countries with high infection rates.
As of March 15, there have been more than 3,000 coronavirus cases confirmed in the United States, driven by more than 200 new cases in New York. At least 800 new cases have been confirmed in the last 24 hours.
The World Health Organization (WHO) has registered over 9,700 new cases of the coronavirus disease (COVID-19) outside of mainland China - Ground Zero for the contagious pneumonia-type infection - bringing the total number infected in the global pandemic to over 167,000, with over 6,400 dead.
Meanwhile, Berlin is trying to stop the US government from persuading a German company that is after a coronavirus vaccine to move its research to the United States, prompting German politicians to insist no country should have a monopoly on any future vaccine.
205/214
Read More:
Over 3,000 cases in the US, death toll climbed to at least 61
Germany hits back over US coronavirus vaccine interest
US State of Georgia postpones presidential primaries due to Coronavirus
